DETD-35

Name: DETD-35 | AN Inhibitor — Buy Online | Immunomart
Brand: TargetMol
SKU: T89997-10 mg

SKU T89997-10 mg Category Small Compound Brand: TargetMol

For Research Use Only (RUO). This product is sold strictly for laboratory research use. Not for human or veterinary consumption, therapeutic, or diagnostic use.For sale to research organizations and laboratories only; not for patients or for personal use.

Products Details

Product Description

– DETD-35 is a promising chemical compound in anti-melanoma therapy, functioning as an inhibitor of the MEK-ERK, Akt, and STAT3 signaling pathways. It enhances cancer cell apoptosis (Apoptosis) and diminishes resistance to Vemurafenib in cancer cells. The compound exhibits IC 50 values of 2.7, 6.0, 3.9, 3.1, and 2.5 μM against melanoma cell lines B16-F10, MeWo, SK-MEL-2, A2058c, and A375c, respectively. DETD-35 offers significant potential for advancing research in melanoma treatment strategies.

For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.

Web ID

– T89997

Storage Temperature

– -20℃

Shipping

– Blue Ice

Molecular Formula

– C27H24O6

CAS Number

– 1836209-98-3

Molecular Weight

– C27H24O6

SMILES

– CC1=C[C@@H](OC(=O)CC2=C3C=CC=CC3=CC=C2)[C@H]2[C@H](CC3=C[C@@H](C1)OC3=O)OC(=O)C2=C

Pathway

– JAK/STAT signaling|||Apoptosis|||MAPK|||Cytoskeletal Signaling|||Stem Cells|||PI3K/Akt/mTOR signaling

Product type

– Small Compound

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.